Sign In
Buy CSBR
$5.69
-0.0350 (-0.611%)
At Close: Jun 03, 2026
Champions Oncology's European Research Operations Site Receives ISO-9001:2015 Accreditation and ATS Certification
08:30am, Thursday, 02'nd Nov 2023
HACKENSACK, NJ / ACCESSWIRE / November 2, 2023 / Champions Oncology, Inc. (NASDAQ:CSBR), a global preclinical and clinical research services provider that offers end-to-end oncology solutions, announc
Champions Oncology Announces the Addition of Brady Davis as President
08:30am, Tuesday, 17'th Oct 2023
HACKENSACK, NJ / ACCESSWIRE / October 17, 2023 / Champions Oncology, Inc. (Nasdaq:CSBR), a global preclinical and clinical research services provider that offers end-to-end oncology solutions, has app
Champions Oncology, Inc. (CSBR) Q1 2024 Earnings Call Transcript
01:34pm, Friday, 15'th Sep 2023
Champions Oncology, Inc. (NASDAQ:CSBR ) Q1 2024 Earnings Conference Call September 13, 2023 4:30 PM ET Company Participants Ronnie Morris - CEO David Miller - CFO Conference Call Participants Matt Hew
Champions Oncology Reports Quarterly Revenue of $12.6 Million
04:00pm, Wednesday, 13'th Sep 2023
HACKENSACK, NJ / ACCESSWIRE / September 13, 2023 / Champions Oncology, Inc. (Nasdaq:CSBR), a leading global technology-enabled biotech that is transforming drug discovery through innovative AI-driven
Champions Oncology to Announce First Quarter Financial Results on Wednesday, September 13, 2023
04:00pm, Monday, 11'th Sep 2023
HACKENSACK, NJ / ACCESSWIRE / September 11, 2023 / Champions Oncology, Inc. (CSBR), a leading global technology-enabled biotech that is transforming drug discovery through innovative AI-driven pharmac
Champions Oncology Aannounces Remarkable Lineup of Speakers at Its Translational Oncology Symposium in Boston in September 2023
08:30am, Tuesday, 22'nd Aug 2023
HACKENSACK, NJ / ACCESSWIRE / August 22, 2023 / Champions Oncology, Inc. (NASDAQ:CSBR), a global preclinical and clinical research services provider that offers end-to-end oncology solutions, kicks-of
HACKENSACK, NJ / ACCESSWIRE / August 1, 2023 / Champions Oncology, Inc. (NASDAQ:CSBR), a leading global preclinical and clinical research services provider that offers end-to-end oncology R&D solution
Champions Oncology, Inc. (CSBR) Q4 2023 Earnings Call Transcript
06:34pm, Monday, 24'th Jul 2023
Champions Oncology, Inc. (NASDAQ:CSBR ) Q4 2023 Earnings Conference Call July 24, 2023 4:30 PM ET Company Participants Ronnie Morris - Chief Executive Officer David Miller - Chief Financial Officer Co
Champions Oncology Reports Quarterly Revenue of $13.1 Million
04:00pm, Monday, 24'th Jul 2023
Record Annual Revenue of $53.9 Million HACKENSACK, NJ / ACCESSWIRE / July 24, 2023 / Champions Oncology, Inc. (Nasdaq:CSBR), a leading global technology-enabled biotech that is transforming drug disco
Champions Oncology to Announce Fourth Quarter and Year-End Financial Results on Monday, July 24, 2023
04:00pm, Thursday, 20'th Jul 2023
HACKENSACK, NJ / ACCESSWIRE / July 20, 2023 / Champions Oncology, Inc. (CSBR), a leading global technology-enabled biotech that is transforming drug discovery through innovative AI-driven pharmaco-phe
Champions Oncology, Inc. (CSBR) Reports Q3 Loss, Tops Revenue Estimates
06:19pm, Wednesday, 15'th Mar 2023
Champions Oncology, Inc. (CSBR) delivered earnings and revenue surprises of -200% and 2.26%, respectively, for the quarter ended January 2023. Do the numbers hold clues to what lies ahead for the stoc
Champions Oncology to Announce Third Quarter Financial Results on Wednesday, March 15, 2023
08:30am, Monday, 13'th Mar 2023
HACKENSACK, NJ / ACCESSWIRE / March 13, 2023 / Champions Oncology, Inc. (NASDAQ:CSBR), a leading global technology-enabled biotech that is transforming drug discovery through innovative AI-driven phar
Champions Oncology Trades At A Sufficient Discount To R&D Capacity
12:37am, Sunday, 29'th Jan 2023
CSBR runs a PDX bank. PDXs are mice models of human derived tumors. The company offers services to bio and pharma companies in pre clinical treatment testing. Its test have high predictive power for h
Champions Oncology, Inc. (CSBR) Q2 2023 Earnings Call Transcript
08:54pm, Tuesday, 13'th Dec 2022
Champions Oncology, Inc. (NASDAQ:CSBR ) Q2 2023 Results Conference Call December 13, 2022 4:30 PM ET Company Participants Ronnie Morris - CEO David Miller - CFO Conference Call Participants Scott Henr
Champions Oncology to Announce Second Quarter Financial Results on Tuesday, December 13, 2022
04:30pm, Friday, 09'th Dec 2022
HACKENSACK, NJ / ACCESSWIRE / December 9, 2022 / Champions Oncology, Inc. (CSBR), a leading global technology-enabled biotech that is transforming drug discovery through innovative AI-driven pharmaco-
